Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2015

Planlagt Fastgjort Låst Flyttet Genmab
2.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • investor1989I Offline
    investor1989I Offline
    investor1989
    wrote on sidst redigeret af
    #874

    Der er kommet agenda for J&J dagen nu: http://www.investor.jnj.com/webcasts-presentations.cfm

    1 Reply Last reply
    0
    • investor1989I Offline
      investor1989I Offline
      investor1989
      wrote on sidst redigeret af
      #875

      Peter Lebowitz gennemgår oncology 1 pm. så nok der vi skal være obs

      1 Reply Last reply
      0
      • G Offline
        G Offline
        gentogen
        wrote on sidst redigeret af
        #876

        "Janssen oncology is poised for another strong showing at ASCO this year, showcasing our continued strides to make a difference in the lives of people living with cancer," said Peter F. Lebowitz, M.D., Ph.D., Global Oncology Head, Janssen. "Of the five Janssen compounds being featured, we are particularly excited about new daratumumab monotherapy data in multiple myeloma

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #877

          Link Preview Image
          Janssen to Showcase Data from Five Compounds Including Daratumumab and IMBRUVICA at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting

          /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced that data from five oncology treatments across the portfolio, including marketed and...

          favicon

          (www.prnewswire.com)

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #878

            GMXAY endte i +0,23%. (+10% i går). NBI +1,27%

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #879

              God morgen. 🙂

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #880

                Lyt med på Millionærklubben i dag. Jeg snakker biotek - og selvfølgelig også Genmab.

                1 Reply Last reply
                0
                • celsiusC Offline
                  celsiusC Offline
                  celsius
                  wrote on sidst redigeret af
                  #881

                  Positive fase 1-data for Genmabs mest potente antistof.. Se Medwatch idag ..

                  1 Reply Last reply
                  0
                  • R Offline
                    R Offline
                    Repsac
                    wrote on sidst redigeret af
                    #882

                    Helge: Kan du kopiere Q&A over i debatten?

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #883

                      Det kommer senere i dag. 🙂

                      1 Reply Last reply
                      0
                      • FantomasF Offline
                        FantomasF Offline
                        Fantomas
                        wrote on sidst redigeret af
                        #884

                        Link Preview Image
                        Siden findes ikke

                        favicon

                        (borsen.dk)

                        1 Reply Last reply
                        0
                        • FantomasF Offline
                          FantomasF Offline
                          Fantomas
                          wrote on sidst redigeret af
                          #885

                          Nordea: Genmab spurter fra internationale rivaler

                          1 Reply Last reply
                          0
                          • investor1989I Offline
                            investor1989I Offline
                            investor1989
                            wrote on sidst redigeret af
                            #886

                            Spændende artikler
                            Ser godt ud
                            Jeffr
                            ies også med stor analyse

                            1 Reply Last reply
                            0
                            • FantomasF Offline
                              FantomasF Offline
                              Fantomas
                              wrote on sidst redigeret af
                              #887

                              Har du link til analysen fra Jeffries?

                              1 Reply Last reply
                              0
                              • royalR Offline
                                royalR Offline
                                royal
                                wrote on sidst redigeret af
                                #888

                                Lidt ærgerligt at Børsen har lukket idag. 😞

                                1 Reply Last reply
                                0
                                • royalR Offline
                                  royalR Offline
                                  royal
                                  wrote on sidst redigeret af
                                  #889

                                  Kunne være interessant at se hvordan markedet reagerer.

                                  1 Reply Last reply
                                  0
                                  • investor1989I Offline
                                    investor1989I Offline
                                    investor1989
                                    wrote on sidst redigeret af
                                    #890

                                    det står i medwatch fantomas

                                    1 Reply Last reply
                                    0
                                    • FantomasF Offline
                                      FantomasF Offline
                                      Fantomas
                                      wrote on sidst redigeret af
                                      #891

                                      Tak, mit prøve abonnement er desværre udløbet, så jeg har ikke fuld adgang til srtiklen.

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #892

                                        Winkel oplyser, at Genmab vil gå efter 3 indikationer med TF, hvor der i dag ikke er den store konkurrence - altså ingen god behandlingsmulighed. De vil stadig beholde ejerskabet af stoffet selvom der er interesse fra Pharma til at tegne licens-aftaler
                                        !

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #893

                                          Selv om de 3 indikationer tilsammen ikke har et marked der er større end dara så vil værdien for aktionærer/Genmab være den samme grundet det større ejerforhold. Ham mener altså er den næste guldklump ligger her - data på ASCO må så bevise dette (solsens konklusion)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger